Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful

Journal of Vascular Surgery

Volumn 62, Issue 1, 2015, Pages 166-176.e2

  Scali, Salvatore ^a   Patel, Virendra ^b   Neal, Daniel ^a   Bertges, Daniel ^c   Ho, Karen ^d   Jorgensen, Jens Eldrup ^e   Cronenwett, Jack ^f   Beck, Adam ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MAINE MEDICAL CENTER   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; ELECTIVE SURGERY; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; VASCULAR SURGERY; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG ADMINISTRATION; FACTUAL DATABASE; HEART DISEASES; MORTALITY; MULTICENTER STUDY; PROPENSITY SCORE; RISK; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; ELECTIVE SURGICAL PROCEDURES; HEART DISEASES; HUMANS; LOGISTIC MODELS; ODDS RATIO; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 84937398359     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2015.01.053     Document Type: Article

References (33)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
2. P.E. Norman, K. Jamrozik, M.M. Lawrence-Brown, M.T. Le, C.A. Spencer, R.J. Tuohy, and et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm BMJ 329 2004 1259
3. M. Takigawa, T. Yoshimuta, K. Akutsu, S. Takeshita, and N. Yokoyama Prevalence and predictors of coexistent silent atherosclerotic cardiovascular disease in patients with abdominal aortic aneurysm without previous symptomatic cardiovascular diseases Angiology 63 2012 380 385
4. G. Giugliano, E. Laurenzano, C. Rengo, G. De Rosa, L. Brevetti, A. Sannino, and et al. Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors BMC Surg 12 Suppl 1 2012 S17
5. H.J. Priebe Perioperative myocardial infarction - aetiology and prevention Br J Anaesth 95 2005 3 19
6. L.A. Fleisher, J.A. Beckman, K.A. Brown, H. Calkins, E.L. Chaikof, K.E. Fleischmann, and et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task force on practice guidelines Circulation 120 2009 e169 e276
7. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, and et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur Heart J 28 2007 2375 2414
8. S. Bangalore, J. Wetterslev, S. Pranesh, S. Sawhney, C. Gluud, and F.H. Messerli Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis Lancet 372 2008 1962 1976
9. S. Bouri, M.J. Shun-Shin, G.D. Cole, J. Mayet, and D.P. Francis Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery Heart 100 2014 456 464
10. P.P. Goodney, J. Eldrup-Jorgensen, B.W. Nolan, D.J. Bertges, D.S. Likosky, and J.L. Cronenwett A regional quality improvement effort to increase beta blocker administration before vascular surgery J Vasc Surg 53 2011 1316 1328.e1311 discussion: 1327-8
11. P.J. Devereaux, H. Yang, S. Yusuf, G. Guyatt, K. Leslie, J.C. Villar, and et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 2008 1839 1847
12. V. Chopra, and K.A. Eagle Perioperative mischief: the price of academic misconduct Am J Med 125 2012 953 955
13. J.L. Cronenwett, L.W. Kraiss, and R.P. Cambria The Society for Vascular Surgery Vascular Quality Initiative J Vasc Surg 55 2012 1529 1537
14. K. Woo, J. Eldrup-Jorgensen, J.W. Hallett, M.G. Davies, A. Beck, G.R. Upchurch Jr. , and et al. Regional quality groups in the Society for Vascular Surgery® Vascular Quality Initiative J Vasc Surg 57 2013 884 890
15. E. Boersma, D. Poldermans, J.J. Bax, E.W. Steyerberg, I.R. Thomson, J.D. Banga, and et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy JAMA 285 2001 1865 1873
16. D.J. Bertges, P.P. Goodney, Y. Zhao, A. Schanzer, B.W. Nolan, D.S. Likosky, and et al. The vascular study group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the revised cardiac risk index in vascular surgery patients J Vasc Surg 52 2010 674 683 683.e671-3
17. J.L. Cronenwett, D.S. Likosky, M.T. Russell, J. Eldrup-Jorgensen, A.C. Stanley, and B.W. Nolan A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE) J Vasc Surg 46 2007 1093 1101 discussion: 1101-2
18. T.H. Lee, E.R. Marcantonio, C.M. Mangione, E.J. Thomas, C.A. Polanczyk, E.F. Cook, and et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circulation 100 1999 1043 1049
19. D.T. Mangano, E.L. Layug, A. Wallace, and I. Tateo Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group N Engl J Med 335 1996 1713 1720
20. D. Poldermans, E. Boersma, J.J. Bax, I.R. Thomson, L.L. van de Ven, J.D. Blankensteijn, and et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group N Engl J Med 341 1999 1789 1794
21. J.D. Birkmeyer, and J.B. Dimick Potential benefits of the new Leapfrog standards: effect of process and outcomes measures Surgery 135 2014 569 575
22. L.L. Leape, D.M. Berwick, and D.W. Bates What practices will most improve safety? Evidence-based medicine meets patient safety JAMA 288 2002 501 507
23. Shojania KG, Duncan BW, McDonald KM, Wachter RW. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Available at: http://www.ahrq.gov/research/findings/evidence-based-reports/services/quality/ptsafetysum.html.
24. K.A. Eagle, P.B. Berger, H. Calkins, B.R. Chaitman, G.A. Ewy, K.E. Fleischmann, and et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation 105 2002 1257 1267
25. A.R. Brady, J.S. Gibbs, R.M. Greenhalgh, J.T. Powell, and M.R. Sydes Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial J Vasc Surg 41 2005 602 609
26. A.B. Juul, J. Wetterslev, C. Gluud, A. Kofoed-Enevoldsen, G. Jensen, T. Callesen, and et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial BMJ 332 2006 1482
27. H. Yang, K. Raymer, R. Butler, J. Parlow, and R. Roberts The effects of perioperative beta-blockade: results of the Metoprolol After Vascular Surgery (MAVS) study, a randomized controlled trial Am Heart J 152 2006 983 990
28. P.K. Lindenauer, P. Pekow, K. Wang, D.K. Mamidi, B. Gutierrez, and E.M. Benjamin Perioperative beta-blocker therapy and mortality after major noncardiac surgery N Engl J Med 353 2005 349 361
29. L.A. Fleisher, J.A. Beckman, K.A. Brown, H. Calkins, E. Chaikof, K.E. Fleischmann, and et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology Circulation 113 2006 2662 2674
30. M. Dunkelgrun, E. Boersma, O. Schouten, A.W. Koopman-van Gemert, F. van Poorten, J.J. Bax, and et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV) Ann Surg 249 2009 921 926
31. Erasmus Medical Center Follow-up Investigation Committee. Investigation into possible violation of scientific integrity: report summary. Rotterdam, The Netherlands: Eramus Medical Center; September 30, 2012. Available online: http://www.erasmusmc.nl/1172194/2090115/Integrity-report-2012-10.pdf.
32. M.J. London, K. Hur, G.G. Schwartz, and W.G. Henderson Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery JAMA 309 2013 1704 1713
33. D.N. Wijeysundera, D. Duncan, C. Nkonde-Price, S.S. Virani, J.B. Washam, K.E. Fleischmann, and et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 130 2014 2246 2264